Perioperative Management of Oral Glucose-lowering Drugs in the Patient with Type 2 Diabetes

被引：35
|
作者：
Preiser, Jean-Charles [1 ]
Provenzano, Bruna [1 ]
Mongkolpun, Wasineeart [1 ]
Halenarova, Katarina [1 ]
Cnop, Miriam [2 ,3 ]
机构：
[1] Free Univ Brussels, Dept Intens Care, Brussels, Belgium
[2] Free Univ Brussels, Erasmus Hosp, Div Endocrinol, Brussels, Belgium
[3] Free Univ Brussels, Ctr Diabet Res, Brussels, Belgium
来源：
ANESTHESIOLOGY | 2020年 / 133卷 / 02期
关键词：
COTRANSPORTER-2; INHIBITORS; CARDIOVASCULAR EVENTS; LACTIC-ACIDOSIS; BLOOD-GLUCOSE; METFORMIN; HYPERGLYCEMIA; DEATH; RISK; MORTALITY; SURGERY;
D O I：
10.1097/ALN.0000000000003237
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
[No abstract available]
引用
收藏
页码：430 / 438
页数：9
相关论文
共 50 条
  • [41] Comparison of glucose-lowering drugs
    Kang, Seema
    LANCET DIABETES & ENDOCRINOLOGY, 2016, 4 (09): : 736 - 736
  • [42] Are patients with schizophrenia treated less with second-line glucose-lowering drugs for type 2 diabetes?
    Jacobsen, Soren L.
    Kohler-Forsberg, Ole
    Rohde, Christopher
    SCHIZOPHRENIA RESEARCH, 2024, 270 : 231 - 234
  • [43] Can glucose-lowering drugs affect the prognosis of COVID-19 in patients with type 2 diabetes?
    Schernthaner, Guntram
    LANCET DIABETES & ENDOCRINOLOGY, 2021, 9 (05): : 251 - 252
  • [44] Cardiovascular outcome trials of glucose-lowering drugs in type 2 diabetes: 10 frequently asked questions
    George, Jyothis T.
    PRACTICAL DIABETES, 2015, 32 (08) : 301 - 304
  • [45] MONITORING UTILIZATION TRENDS OF GLUCOSE-LOWERING DRUGS FOR TYPE 2 DIABETES IN OLDER ADULTS BY FRAILTY STATUS
    Gopalakrishnan, Chandrasekar
    Kim, Dae
    Kutz, Alexander
    Patorno, Elisabetta
    INNOVATION IN AGING, 2021, 5 : 208 - 208
  • [46] Glucose-lowering drugs and heart failure: implications of recent cardiovascular outcome trials in type 2 diabetes
    Cattadori, Gaia
    Pantanetti, Paola
    Ambrosio, Giuseppe
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2019, 157
  • [47] Mechanisms of glucose-lowering effect by rosiglitazone in patients with type 2 diabetes
    Miyazaki, Y
    Matsuda, M
    Mahankali, A
    Mahankali, S
    Cusi, K
    Mandarino, L
    Defronzo, R
    DIABETES, 2001, 50 : A126 - A127
  • [48] Glucose-lowering therapies in type 2 diabetes: Opportunities and challenges for peptides
    Bailey, Clifford J.
    PEPTIDES, 2018, 100 : 9 - 17
  • [49] Cardiovascular outcome trials of glucose-lowering strategies in type 2 diabetes
    Yudkin, John S.
    Vijan, Sandeep
    Sussman, Jeremy B.
    Lehman, Richard
    Goldacre, Ben M.
    LANCET, 2014, 384 (9948): : 1095 - 1095
  • [50] INFLUENCE OF GLUCOSE-LOWERING STRATEGIES ON FRACTURE RISK IN TYPE 2 DIABETES
    Gusova, A. A.
    Pavlova, M. G.
    Melnitchenko, G. A.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 : S160 - S161
12345